Key Highlights

Issue Type: Entirely an Offer for Sale (OFS)

IPO Size: ₹846.25 crore (1.92 crore shares)

Price Band: ₹420–₹441 per share

Minimum Lot Size: 34 shares, ₹14,994 minimum investment

Listing: Shares will list on NSE and BSE

Book Running Lead Managers: ICICI Securities, Nuvama Wealth Management, and SBI Capital Markets

Company Overview

Suraksha Diagnostics, established in 2005, is a leading diagnostics service provider in eastern India. The company offers pathology, radiology, and medical consultancy services, with infrastructure comprising:

1 central reference laboratory

8 satellite labs

215 touchpoints, including diagnostic centers and collection centers

The services are accredited by CAP and NABL, ensuring quality standards​

IPO Schedule

Anchor Investors Allocation: November 28, 2024

Open Dates: November 29 – December 3, 2024

Allotment Finalization: December 4, 2024

Refund Initiation: December 5, 2024

Credit of Shares: December 5, 2024

Listing Date: December 6, 2024.

Objective

The IPO does not involve a fresh issue of shares; the proceeds will be used to provide an exit to existing shareholders, with no direct impact on company operations or growth funding​

Subscription Status

As of December 3, 2024 (early estimates):

Retail: 0.75x subscribed

Non-Institutional Investors (NII): 0.85x subscribed

Qualified Institutional Buyers (QIB): 1.52x subscribed

Overall: Approximately 1.19x subscribed​.

Strengths and Risks

Strengths:

Market leader in eastern India with strong brand recognition.

Advanced clinical infrastructure.

Comprehensive diagnostic offerings spanning pathology and radiology.

Risks:

Dependency on operations in West Bengal (regional concentration).

High competition in the diagnostics sector.

Reliance on third-party vendors for equipment.

Financial agreements and debt may limit flexibility​.

If you’d like to participate, applications close by 5 PM on December 3, 2024. Visit platforms like Zerodha, 5Paisa, or the registrar’s site for application processes and allotment updates.

Also read: Apple Inc.: Competitive Advantage, Mission, Vision & Core Values